UAB: Hodgkin’s Lymphoma drug shows promise - WSFA.com Montgomery Alabama news.

UAB: Hodgkin's Lymphoma drug shows promise

BIRMINGHAM, AL (WBRC) – Researchers at UAB feel they are making progress against Hodgkin's lymphoma after an experimental drug showed beneficial effects in stopping tumor growth with only moderate side-effects.

The new drug, brentuximab vedotin(SGN-35), was tested to find the maximum tolerated dose without adverse side effects in the Phase 1 trial.  Out of 45 patients in the study, 17 reported positive responses to the medicine. Eleven of the positive responses were complete remissions.

UAB says this is quite a breakthrough because 30% of Hodgkin's patients do not respond to conventional therapy. The patients using the new drug showed tumor regression in 36 out of the 42 patients and the duration of the effects lasted more than 9 months.

"There is a large percentage of patients with Hodgkin's lymphoma or anaplastic large-cell lymphoma who do not respond well to traditional therapies such as chemotherapy or autologous stem-cell transplantation," said Forero-Torres. "SNG-35 appears to be satisfactorily tolerated at 1.8 mg and may offer promise to those patients for whom other therapies have proven to be unsuccessful."

Copyright 2010 WBRC. All rights reserved.

  • Trending StoriesTrending StoriesMore>>

  • Homeless man gets makeover from big-hearted cops

    Homeless man gets makeover from big-hearted cops

    Tuesday, April 25 2017 2:44 PM EDT2017-04-25 18:44:10 GMT
    Tuesday, April 25 2017 3:49 PM EDT2017-04-25 19:49:50 GMT

    Police officers in Rome, NY, went the extra mile to give back to their community, helping one in need.

    More >>

    Police officers in Rome, NY, went the extra mile to give back to their community, helping one in need.

    More >>
  • Teen with cerebral palsy denied prom tickets

    Teen with cerebral palsy denied prom tickets

    Friday, April 28 2017 10:36 PM EDT2017-04-29 02:36:27 GMT
    Friday, April 28 2017 11:00 PM EDT2017-04-29 03:00:47 GMT
    Ashley Hamblin already has her dress picked out, but may not be able to wear it. (WSMV)Ashley Hamblin already has her dress picked out, but may not be able to wear it. (WSMV)

    She has her dress, her date, and an extensive hair and makeup plan. It’s all in anticipation of her high school prom, but a Middle Tennessee teen was denied tickets.

    More >>

    She has her dress, her date, and an extensive hair and makeup plan. It’s all in anticipation of her high school prom, but a Middle Tennessee teen was denied tickets.

    More >>
  • Severe reaction to new sandals leads woman on a painful path

    Severe reaction to new sandals leads woman on a painful path

        One woman wants to warn people about her painful path, the result of a severe and debilitating allergic reaction.  She had no idea what she was allergic to until she visited a fourth emergency room in two weeks.    

    More >>

    One woman wants to warn people about her painful path, the result of a severe and debilitating allergic reaction. She had no idea what she was allergic to until she visited a fourth emergency room in two weeks.    

    More >>
Powered by Frankly